Open AccessThe allergic eye: recommendations about pharmacotherapy and recent therapeutic agents
Author(s) -
Nofar Kimchi,
Leonard Bielory
Publication year - 2020
Publication title -
current opinion in allergy and clinical immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.94
H-Index - 84
eISSN - 1528-4050
pISSN - 1473-6322
DOI - 10.1097/aci.0000000000000669
Subject(s) - medicine , intensive care medicine , pharmacotherapy , adverse effect , allergic conjunctivitis , quality of life (healthcare) , drug , allergy , pharmacology , immunology , psychiatry , nursing
Ocular allergies affect an estimated 40% of the population, 98% of which are because of allergic conjunctivitis. With the current advent of both repurposed drugs for ocular allergies, as well as novel drugs and methods of administration, there is a need for an updated review of current available medications. A clear characterization of each treatment will ultimately allow treating physicians to restore patients' quality of life and decrease burden of disease.